Literature DB >> 4042459

The course of metastatic disease originating from carcinoma of the prostate.

S Plesnicar.   

Abstract

The purpose of this work was to study the time sequence and the patterns of the multistep spread of metastases. Fifty-one patients with stage D carcinoma of the prostate, previously treated for their primary tumor by surgery or radiotherapy combined with hormonal manipulation and for metastases by hormones and chemotherapy, were included in the study. The metastatic dissemination, characterized primarily by the appearance of bone metastases, could follow two distinct patterns: The first, characterized by sequential appearance of osteoblastic metastases, followed by the development of osteolytic bone lesions, and the second pattern, characterized by the simultaneous appearance of osteoblastic and osteolytic bone lesions. In cases with solely osteoblastic bone metastases, the lesions are hormone sensitive and long-lasting remissions could be obtained. The development of osteolytic bone lesions is usually accompanied by the recurrence of the primary tumor and appearance of metastases in other sites, such as the lymph nodes and lungs. Bone metastases became resistant to hormonal manipulation and with chemotherapy short remissions were obtained. The course of the terminal period is faster, with shorter survival times. The determination of serum acid and alkaline phosphatase levels seems to reflect the course of the disease during the initial period of the disease only, i.e. when bone metastases are sensitive to hormonal treatment.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4042459     DOI: 10.1007/bf01758959

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  9 in total

1.  The spread of prostatic carcinoma to the bones.

Authors:  L M FRANKS
Journal:  J Pathol Bacteriol       Date:  1953-07

2.  Proceedings: The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate.

Authors:  D P Byar
Journal:  Cancer       Date:  1973-11       Impact factor: 6.860

3.  Prostatic carcinoma: the relationship between histologic grade and incidence of early metastases.

Authors:  S N Rous; C Mallouh
Journal:  J Urol       Date:  1972-12       Impact factor: 7.450

4.  [Extraosseous metastases of carcinoma of the prostate (author's transl)].

Authors:  P Weber; H Oeser; V Taenzer; H Rost; A Kêlami
Journal:  Dtsch Med Wochenschr       Date:  1974-10-25       Impact factor: 0.628

5.  Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.

Authors:  D F Gleason; G T Mellinger
Journal:  J Urol       Date:  1974-01       Impact factor: 7.450

6.  Prognosis in patients with carcinoma of the prostate.

Authors:  J N Corriere; J L Cornog; J J Murphy
Journal:  Cancer       Date:  1970-04       Impact factor: 6.860

7.  The metastatic spread of kidney and prostate cancers in man.

Authors:  E Viadana; I D Bross; J W Pickren
Journal:  Neoplasma       Date:  1976       Impact factor: 2.575

8.  The dedifferentiation of prostate carcinoma.

Authors:  P N Brawn
Journal:  Cancer       Date:  1983-07-15       Impact factor: 6.860

9.  Immunochemical detection of serum prostatic acid phosphatase. Methodology and clinical evaluation.

Authors:  T M Chu; M C Wang; W W Scott; R P Gibbons; D E Johnson; J D Schmidt; S A Loening; G R Prout; G P Murphy
Journal:  Invest Urol       Date:  1978-01
  9 in total
  6 in total

1.  Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formation.

Authors:  Hongren Yao; Donna M Veine; Zhao-Zhu Zeng; Kevin S Fay; Evan D Staszewski; Donna L Livant
Journal:  Clin Exp Metastasis       Date:  2010-03-26       Impact factor: 5.150

2.  A 73-year-old man with congestion and mild proptosis of the left eye.

Authors:  Amanda Mohanan-Earatt; Lathika Vasu Kamaladevi; Charles K Skariah
Journal:  Digit J Ophthalmol       Date:  2016-04-25

3.  Bone cell matrix promotes the adhesion of human prostatic carcinoma cells via the alpha 2 beta 1 integrin.

Authors:  P J Kostenuik; O Sanchez-Sweatman; F W Orr; G Singh
Journal:  Clin Exp Metastasis       Date:  1996-01       Impact factor: 5.150

4.  A quantitative model for spontaneous bone metastasis: evidence for a mitogenic effect of bone on Walker 256 cancer cells.

Authors:  P J Kostenuik; G Singh; K L Suyama; F W Orr
Journal:  Clin Exp Metastasis       Date:  1992-11       Impact factor: 5.150

5.  Extraconal Orbital Soft Tissue Metastasis Secondary to Prostate Cancer: An Unusual Presentation.

Authors:  Sakshi Kapur; Han Xiao
Journal:  World J Oncol       Date:  2014-06-25

6.  Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma.

Authors:  Ming Yin; Rajiv Dhir; Anil V Parwani
Journal:  Diagn Pathol       Date:  2007-10-27       Impact factor: 2.644

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.